Innovation Pharmaceuticals Inc (IPIX)

[Hugon]

Yes, it’s clear in reading this that they are intending a standalone trial. Combination drug treatments are SO common, so it simply seems they are smartly considering all bases covered to give the drug a good shot at all potential treatment options. Maybe for some patients a combo treatment this more effective, maybe for others standalone is more effective. Testing all pathways gives more options.

Again, the headline is buried. The real headline is:

innovation’s Brilacidin Tests Better THAN the Global Standard of Care Drug in human cell line testing